VISTAGEN THERAPEUTICS, INC. Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31)
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) of 768.50 thousand shares for the 1-month period ending 2015-02-13, per its 10-Q filed 2015-02-17.
Discontinued › Notes › Shares
us-gaap:StockIssuedDuringPeriodSharesIssuedForCash · last filed 2015-02-17
- 2015-02-13: Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) 1 month 768.50K shares.
- 2014-11-17: Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) 2 month 165.00K shares.
- 2014-08-08: Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) 1 month 55.00K shares.
- 2014-02-04: Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) 1 month 1.47M shares; Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) 1 month as first filed 780.00K shares.
| Period end | Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) 1 month | Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) 1 month as first filed | Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) 2 month |
|---|---|---|---|
| 2015-02-13 | 768.50K shares 10-Q · filed 2015-02-17 | ||
| 2014-11-17 | 165.00K shares 10-Q · filed 2014-11-19 | ||
| 2014-08-08 | 55.00K shares 10-Q · filed 2014-08-12 | ||
| 2014-02-04 | 1.47M shares 10-K · filed 2014-06-25 | 780.00K shares 10-Q · filed 2014-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |